Viking Therapeutics (VKTX) Ownership - Who Owns Viking Therapeutics?

7,390 Followers

Viking Therapeutics (VKTX) Ownership Overview

2.89% Insiders

17.78% Mutual Funds

0.08% Other Institutional Investors

12.50% ETFs

66.75% Public Companies and Individual Investors

The ownership structure of Viking Therapeutics (VKTX) stock is a mix of institutional, retail, and individual investors. Approximately 30.36% of the company’s stock is owned by Institutional Investors, 2.89% is owned by Insiders, and 66.75% is owned by Public Companies and Individual Investors.

The ownership structure of Viking Therapeutics (VKTX) stock is a mix of institutional, retail, and individual investors. Approximately 17.86% of the company’s stock is owned by Institutional Investors, 2.89% is owned by Insiders, and 12.50% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Mar 10, 2026	Neil William Aubuchon	xxxxxxxxxxxxx	$149913
Jan 05, 2026	Brian Lian	xxxxxxxxxxxxx	$7691296
Jan 05, 2026	Matthew W. Foehr	xxxxxxxxxxxxx	$561600
Jan 05, 2026	Greg Zante	xxxxxxxxxxxxx	$1896692

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2025	Goalvest Advisory Llc	xxxxxxxxxxxxx	$5277
Dec 31, 2025	Soros Fund Mangment Llc	xxxxxxxxxxxxx	$3166200
Dec 31, 2025	Bridgewater Associates, Lp	xxxxxxxxxxxxx	$3646723
Dec 31, 2025	Woodline Partners Lp	xxxxxxxxxxxxx	$10625485

Show More Hedge Fund Trading Activity >

Top Shareholders

# of Shares	Type	% Holding	Value
8,870,494	Institution	7.68%	303,903,124
8,408,937	Institution	7.28%	288,090,182
2,636,820	Institution	2.28%	90,337,453
2,499,291	Insider	2.16%	85,625,710
1,487,761	Institution	1.29%	50,970,692
1,262,263	Institution	1.09%	43,245,130
1,238,621	Institution	1.07%	42,435,155
1,145,823	Institution	0.99%	39,255,896
997,387	Institution	0.86%	34,170,479
996,435	Institution	0.86%	34,137,863

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
8,408,937	Institution	7.28%	288,090,182
1,262,263	Institution	1.09%	43,245,130
1,238,621	Institution	1.07%	42,435,155
1,145,823	Institution	0.99%	39,255,896
997,387	Institution	0.86%	34,170,479
996,435	Institution	0.86%	34,137,863
921,957	Institution	0.80%	31,586,247
782,196	Institution	0.68%	26,798,035
604,745	Institution	0.52%	20,718,564
535,287	Institution	0.46%	18,338,933

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	3,396,489	Institution	2.94%	114,937,188
SPDR S&P BIOTECH ETF	2,622,920	Institution	2.27%	91,671,054
Vanguard Small-Cap ETF	2,437,565	Institution	2.11%	82,487,200
Vanguard Small-Cap Growth ETF	1,355,488	Institution	1.17%	45,869,714
Vanguard Extended Market ETF	1,232,825	Institution	1.07%	41,718,798
Schwab U.S. Small-Cap ETF	559,974	Institution	0.48%	19,571,091
iShares Russell Midcap ETF	423,688	Institution	0.37%	14,515,551
Vanguard Health Care ETF	322,860	Institution	0.28%	10,925,582
iShares Russell 1000 Value ETF	230,221	Institution	0.20%	7,887,371
iShares Core S&P Total U.S. Stock Market ETF	155,047	Institution	0.13%	5,311,910

FAQ

Who Owns Viking Therapeutics (VKTX)?

According to the latest TipRanks data, approximately 0.08% of the company's stock is held by institutional investors, 2.89% is held by insiders, and 66.75% is held by retail investors.

What percentage of Viking Therapeutics (VKTX) stock is held by institutional investors?

According to the latest TipRanks data, approximately 0.08% of Viking Therapeutics (VKTX) stock is held by institutional investors.

What percentage of Viking Therapeutics (VKTX) stock is held by retail investors?

According to the latest TipRanks data, approximately 66.75% of Viking Therapeutics (VKTX) stock is held by retail investors.

Who owns the most shares of Viking Therapeutics (VKTX)?

Vanguard owns the most shares of Viking Therapeutics (VKTX).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.